Small-cap mutual funds ramped up exposure to industrial products and pharmaceutical stocks in May 2026, with Vijaya ...
Dr. Lal Path Labs hits a 52-week high driven by Dubai expansion, strong FY27 growth guidance, solid earnings performance, and ...
Dr Lal PathLabs has incorporated a wholly owned subsidiary, DR LAL PATHLABS FZCO, in Dubai, United Arab Emirates. The ...
Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...
April 25 (Reuters) - Dr Lal Path Labs (DLPA.NS), opens new tab, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its ...
Bengaluru: Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to India's new labour code, despite strong demand for its bundled test packages.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results